|

Zee Live News News, World's No.1 News Portal

LIVE NEWS
Annuities are coming to more 401(k) plans. Should workers embrace them?More than a month into DR Congo Ebola outbreak, doctors warn ‘this epidemic will last’A maple leaf-shaped ‘Canadian clapper’ sparks buzz across TorontoMirabai Chanu to Lead India’s Weightlifting Team at Commonwealth Games 2026, Full Squad AnnouncedWill Meghan Markle’s Presence At Prince Harry’s Reunion With King Charles Change Things?Annuities are coming to more 401(k) plans. Should workers embrace them?More than a month into DR Congo Ebola outbreak, doctors warn ‘this epidemic will last’A maple leaf-shaped ‘Canadian clapper’ sparks buzz across TorontoMirabai Chanu to Lead India’s Weightlifting Team at Commonwealth Games 2026, Full Squad AnnouncedWill Meghan Markle’s Presence At Prince Harry’s Reunion With King Charles Change Things?

FDA

FDA Tightens Its Medical Device Cybersecurity Guidance for Manufacturers

FDA Tightens Its Medical Device Cybersecurity Guidance for Manufacturers

admin_zeelivenews

Granules India to tighten oversight after US FDA warning, exec says

Granules India to tighten oversight after US FDA warning, exec says

admin_zeelivenews

Medtronic gets US FDA nod to use surgical system in cranial, ENT surgeries

Medtronic gets US FDA nod to use surgical system in cranial, ENT surgeries

admin_zeelivenews

Rhythm Pharma wins FDA label expansion for lead drug (RYTM)

Rhythm Pharma wins FDA label expansion for lead drug (RYTM)

admin_zeelivenews

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

admin_zeelivenews

Ozempic’s drug maker, Novo Nordisk, receives FDA warning letter over unreported side effects: What are they? | Company Business News

Ozempic’s drug maker, Novo Nordisk, receives FDA warning letter over unreported side effects: What are they? | Company Business News

admin_zeelivenews

Lupin receives form 483 with 2 observations after US FDA inspection at Ankleshwar facility – CNBC TV18

Lupin receives form 483 with 2 observations after US FDA inspection at Ankleshwar facility – CNBC TV18

admin_zeelivenews

FDA vaccine head will step down in April after string of controversial decisions

FDA vaccine head will step down in April after string of controversial decisions

admin_zeelivenews

FDA reversals leave investors worrying about the fates of other experimental drugs

FDA reversals leave investors worrying about the fates of other experimental drugs

admin_zeelivenews

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

admin_zeelivenews

Previous

Plugin developed by ProSEOBlogger
Facebook
Telegram
Telegram
Plugin developed by ProSEOBlogger. Get free Ypl themes.
Plugin developed by ProSEOBlogger. Get free gpl themes